STAT+: Sanofi research priorities in flux as new CEO logs in

A gene therapy for deafness, all eyes on Erasca, and other biotech news from The Readout
Source
Stat News
Opens original article in a new tab
AI Bias Analysis
4 models · Takes ~15 seconds

A gene therapy for deafness, all eyes on Erasca, and other biotech news from The Readout
Source
Stat News
Opens original article in a new tab

The constant pressure that the heart is under from beating thousands of times a day may create an environment hostile to cancers

The Trump administration, in a stark departure from the "Just Say No" era, is funding psychedelics research and rescheduling marijuana.

(MedPage Today) -- A single dose of mivocabtagene autoleucel (miv-cel), an autologous CD19 chimeric antigen receptor (CAR)-T cell therapy, showed benefit in people with stiff person syndrome (SPS) in the pivotal phase II KYSA-8 trial. The 26-person...

Legislators in two states are resisting efforts to restrict prescription drug affordability boards.